(Q45155067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

Adaptive radiation therapy

8 March 2020

main subject

phase III clinical trial

0 references

0 references

author

Tim M. Illidge

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Peter J Hoskin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2

Amy A Kirkwood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

6

Eve Gallop-Evans

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Bilyana Popova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Paul Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Martin Robinson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Stewart Coltart

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Krishnaswamy Madhavan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Caroline Brammer

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Patricia Diez

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Andrew Jack

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Isabel Syndikus

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

24 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

457-463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970036-1

7 January 2021

Potential role for low dose limited-field radiation therapy (2 x 2 grays) in advanced low-grade non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970036-1

7 January 2021

Localized low-dose radiotherapy for follicular lymphoma: history, clinical results, mechanisms of action, and future outlooks

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970036-1

7 January 2021

High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970036-1

7 January 2021

The role of the p53 pathway in the treatment of follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970036-1

7 January 2021

In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970036-1

7 January 2021

Rituximab enhances radiation-triggered apoptosis in non-Hodgkin's lymphoma cells via caspase-dependent and - independent mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970036-1

7 January 2021

10.1016/S1470-2045(14)70036-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24572077%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference